EyePoint Pharmaceuticals, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
8.72
+1.09 (14.29%)
At close: Jan 22, 2025, 4:00 PM
8.76
+0.04 (0.46%)
After-hours: Jan 22, 2025, 4:42 PM EST
EyePoint Pharmaceuticals Employees
EyePoint Pharmaceuticals had 121 employees as of December 31, 2023. The number of employees decreased by 23 or -15.97% compared to the previous year.
Employees
121
Change (1Y)
-23
Growth (1Y)
-15.97%
Revenue / Employee
$377,793
Profits / Employee
-$855,950
Market Cap
611.80M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
EYPT News
- 6 days ago - EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 14 days ago - EyePoint Appoints Renowned Retina Specialist and Industry Pioneer Reginald J. Sanders, M.D. - GlobeNewsWire
- 7 weeks ago - EyePoint Announces First Patient Dosed in Second Global Phase 3 LUCIA Clinical Trial of DURAVYU™ for the Treatment of Wet Age-Related Macular Degeneration - GlobeNewsWire
- 2 months ago - EyePoint Pharmaceuticals: Low Price And Good Data Create An Opportunity - Seeking Alpha
- 2 months ago - EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - EyePoint Pharmaceuticals Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares - GlobeNewsWire
- 3 months ago - EyePoint Pharmaceuticals Announces Pricing of Upsized Public Offering - GlobeNewsWire
- 3 months ago - EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock - GlobeNewsWire